Concepedia

Moupali Das

MD

48

Publications

5K

Citations

32

H-Index

2010

Active since

Affiliations

Gilead Sciences (United States)(Current)

University of California, San Francisco

San Francisco Department of Public Health

Brigham and Women's Hospital

Johns Hopkins University

Moupali Das is an author at Gilead Sciences (United States) specializing in medicine, hiv, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2010–2024

48

Publications

48

Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco

Moupali Das, Priscilla Lee Chu, Glenn‐Milo Santos et al. · PLoS ONE · 2010 · 777 citations · Full text

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Paul E. Sax, Kristine M. Erlandson, Jordan E. Lake et al. · Clinical Infectious Diseases · 2019 · 723 citations · Full text

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Kenneth H. Mayer, Jean‐Michel Molina, Melanie Thompson et al. · The Lancet · 2020 · 409 citations · Full text

, , +10

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Linda‐Gail Bekker, Moupali Das, Quarraisha Abdool Karim et al. · New England Journal of Medicine · 2024 · 358 citations

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use

Lisa R. Metsch, Daniel J. Feaster, Lauren Gooden et al. · JAMA · 2016 · 189 citations · Full text

Rows per page

1–5 of 48